Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STEPAN COSCL · Entity 4733 | Director · President & CEO | March 08, 2024 | March 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STEPAN CO
Report date March 08, 2024 · Filed March 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,418.404 |
Reported balance
After 2024-03-08 transaction · row 1
1 source rowRow 1 · 2024-03-08 · Tax withholding · Disposed 647 · Balance 14,418.404 F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 1,922 | $76.10 | $146,264.20 |
DisclosureSEC source: 0001127602-17-009693 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,123.071 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 3,553 | $41.16 | $146,241.48 |
DisclosureSEC source: 0001127602-17-009693 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,045.071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 102.495 | $78.91 | $8,087.88 |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,326.516 Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 808 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · derivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · derivative.exercise_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F4 · derivative.expiration_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,545 Underlying: Common Stock · 2,545 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 9,494 | $0.00 Strike: $78.58 | $0.00 |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,494 Underlying: Common Stock · 9,494 shares Expires 2027-02-20 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Option (Right to Buy) · Derivative | 3,165 | $0.00 Strike: $78.58 | $0.00 |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,165 Underlying: Common Stock · 3,165 shares Expires 2027-02-20 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:54 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 725 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-008084 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,492.071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Amount reported reflects vesting of 725 performance shares as shown on Table II due to achievement of certain financial targets by December 31, 2016. Read SEC document |
| February 21, 2017 Filed Mar 7, 2017 23:56 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 1,718 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-17-010717 · form4.xml · derivative · entry 10 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F7 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F7 · derivative.exercise_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. F7 · derivative.expiration_date: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2016. Read SEC document |
| February 21, 2017 Filed Mar 7, 2017 23:56 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,542 | $78.52 | $121,077.84 |
DisclosureSEC source: 0001127602-17-010717 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,140.071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Amount reported reflects vesting of 1,542 performance shares as shown in Table II due to achievement of certain financial targets by December 31, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 23:35 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 20.88 | $84.93 | $1,773.34 |
DisclosureSEC source: 0001127602-16-070484 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,671.166 Underlying: Common Stock · 20.88 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 23:35 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 7.828 | $84.93 | $664.83 |
DisclosureSEC source: 0001127602-16-070484 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,767.071 F2 · balance_after: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 23:35 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 7.744 | $84.93 | $657.70 |
DisclosureSEC source: 0001127602-16-070484 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,224.021 F1 · balance_after: Reflects ESOP II acquisitions that have occurred since the Reporting Person's last ownership report covering ESOP II holdings. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 20:25 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 23.309 | $70.32 | $1,639.09 |
DisclosureSEC source: 0001127602-16-062798 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,650.286 Underlying: Common Stock · 23.309 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 20:25 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 8.74 | $70.32 | $614.60 |
DisclosureSEC source: 0001127602-16-062798 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,759.243 F1 · shares: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.